The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Macrocycles in Drug Discovery─Learning from the Past for the Future
Open accessAbstract
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are mainly used in infectious disease and oncology, while oncology is the major indication for the clinical candidates and in the literature Most macrocyclic drugs bind to targets that have difficult to drug binding sites. Natural products have provided 80-90% of the drugs and clinical candidates, whereas macrocycles in ChEMBL have less complex structures. Macrocycles usually reside in the beyond the Rule of 5 chemical space, but 30-40% of the drugs and clinical candidates are orally bioavailable. Simple bi-descriptor models, i.e., HBD ≤ 7 in combination with either MW < 1000 Da or cLogP > 2.5, distinguished orals from parenterals and can be used as filters in design. We propose that recent breakthroughs in conformational analysis and inspiration from natural products will further improve the de novo design of macrocycles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Newman, D. J., & Cragg, G. M. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01285 · Cited by 7,015
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500588j · Cited by 1,800
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Thoughts and facts about antibiotics: Where we are now and where we are heading
Bérdy, J. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.27 · Cited by 1,165
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Marsault, E., & Peterson, M. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1012374 · Cited by 843
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Self-citationSchreiber, S. L. (2021) · Cell · doi:10.1016/j.cell.2020.12.020 · Cited by 598
Johnson, T. W., Richardson, P. F., Bailey, S., Brooun, A., Burke, B. J., Collins, M. R., Cui, J. J., Deal, J. G., Deng, Y.-L., Dinh, D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500261q · Cited by 594
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Self-citationTowards the Optimal Screening Collection: A Synthesis Strategy
Nielsen, T. E., & Schreiber, S. L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703073 · Cited by 551
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
Macrocycles In New Drug Discovery
Mallinson, J., & Collins, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.93 · Cited by 468
Shultz, M. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00686 · Cited by 434
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection: Miniperspective
DeGoey, D. A., Chen, H.-J., Cox, P. B., & Wendt, M. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00717 · Cited by 378
A Comprehensive Overview of Globally Approved JAK Inhibitors
Shawky, A. M., Almalki, F. A., Abdalla, A. N., Abdelazeem, A. H., & Gouda, A. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051001 · Cited by 349
How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
Doak, B. C., Zheng, J., Dobritzsch, D., & Kihlberg, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01286 · Cited by 335
Self-citationNatural-product-derived fragments for fragment-based ligand discovery
Over, B., Wetzel, S., Grütter, C., Nakai, Y., Renner, S., Rauh, D., & Waldmann, H. (2013) · Nature Chemistry · doi:10.1038/nchem.1506 · Cited by 300
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
Whitty, A., Zhong, M., Viarengo, L., Beglov, D., Hall, D. R., & Vajda, S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.005 · Cited by 285
Why big pharma has abandoned antibiotics
Plackett, B. (2020) · Nature · doi:10.1038/d41586-020-02884-3 · Cited by 278
Conformational Restriction: An Effective Tactic in ‘Follow-On’-Based Drug Discovery
Fang, Z., Song, Y., Zhan, P., Zhang, Q., & Liu, X. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.50 · Cited by 268
Hydrogen-Bond Donors in Drug Design
Kenny, P. W. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01147 · Cited by 241
Rossi Sebastiano, M., Doak, B. C., Backlund, M., Poongavanam, V., Over, B., Ermondi, G., Caron, G., Matsson, P., & Kihlberg, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00347 · Cited by 234
Self-citationStrategies for the Diversity-Oriented Synthesis of Macrocycles
Mortensen, K. T., Osberger, T. J., King, T. A., Sore, H. F., & Spring, D. R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00084 · Cited by 234
What can a chemist learn from nature?s macrocycles? ? A brief, conceptual view
Wessjohann, L. A., Ruijter, E., Garcia-Rivera, D., & Brandt, W. (2005) · Molecular Diversity · doi:10.1007/s11030-005-1314-x · Cited by 222
Principle and design of pseudo-natural products
Karageorgis, G., Foley, D. J., Laraia, L., & Waldmann, H. (2020) · Nature Chemistry · doi:10.1038/s41557-019-0411-x · Cited by 213
Chemical Evolution of Natural Product Structure
Grigalunas, M., Brakmann, S., & Waldmann, H. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c11270 · Cited by 213
Structural and conformational determinants of macrocycle cell permeability
Over, B., Matsson, P., Tyrchan, C., Artursson, P., Doak, B. C., Foley, M. A., Hilgendorf, C., Johnston, S. E., Lee, M. D., Lewis, R. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2203 · Cited by 209
Self-citationCheminformatic comparison of approved drugs from natural product versus synthetic origins
Stratton, C. F., Newman, D. J., & Tan, D. S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.014 · Cited by 191
AI in small-molecule drug discovery: a coming wave?
Jayatunga, M. K. P., Xie, W., Ruder, L., Schulze, U., & Meier, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/d41573-022-00025-1 · Cited by 187
Accurate de novo design of membrane-traversing macrocycles
Bhardwaj, G., O’Connor, J., Rettie, S., Huang, Y.-H., Ramelot, T. A., Mulligan, V. K., Alpkilic, G. G., Palmer, J., Bera, A. K., Bick, M. J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.019 · Cited by 172
Conformational Control of Macrocycles by Remote Structural Modification
Appavoo, S. D., Huh, S., Diaz, D. B., & Yudin, A. K. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00742 · Cited by 157
Cummings, M. D., & Sekharan, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01985 · Cited by 139
Why Some Targets Benefit from beyond Rule of Five Drugs
Egbert, M. E., Whitty, A., Keserű, G. M., & Vajda, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01732 · Cited by 134
Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs
Danelius, E., Poongavanam, V., Peintner, S., Wieske, L. H. E., Erdélyi, M., & Kihlberg, J. O. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905599 · Cited by 131
Self-citationCyclosporin Structure and Permeability: From A to Z and Beyond
Corbett, K. M., Ford, L., Warren, D. B., Pouton, C. W., & Chalmers, D. K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00580 · Cited by 114
The Time and Place for Nature in Drug Discovery
Young, R. J., Flitsch, S. L., Grigalunas, M., Leeson, P. D., Quinn, R. J., Turner, N. J., & Waldmann, H. (2022) · JACS Au · doi:10.1021/jacsau.2c00415 · Cited by 113
Deep Learning Approaches in Predicting ADMET Properties
Cáceres, E. L., Tudor, M., & Cheng, A. C. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0259 · Cited by 108
Poongavanam, V., Danelius, E., Peintner, S., Alcaraz, L., Caron, G., Cummings, M. D., Wlodek, S. T., Erdélyi, M., Hawkins, P. C. D., Ermondi, G., et al. (2018) · ACS Omega · doi:10.1021/acsomega.8b01379 · Cited by 93
Self-citationDeLorbe, J. E., Clements, J. H., Whiddon, B. B., & Martin, S. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100142y · Cited by 88
Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide
Alogheli, H., Olanders, G., Schaal, W., Brandt, P., & Karlén, A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00443 · Cited by 88
Drug‐Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side‐Chain Lipophilicity
Furukawa, A., Schwochert, J., Pye, C. R., Asano, D., Edmondson, Q. D., Turmon, A. C., Klein, V. G., Ono, S., Okada, O., & Lokey, R. S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004550 · Cited by 79
Mackman, R. L., Steadman, V. A., Dean, D. K., Jansa, P., Poullennec, K. G., Appleby, T. C., Austin, C., Blakemore, C. A., Cai, R. Z., Cannizzaro, C. E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00802 · Cited by 79
Conformational Analysis of Macrocycles: Finding What Common Search Methods Miss
Bonnet, P., Agrafiotis, D. K., Zhu, F., & Martin, É. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900238a · Cited by 67
Rembratt, A., Graugaard-Jensen, C., Senderovitz, T., Norgaard, J., & Djurhuus, J. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0781-9 · Cited by 62
Ermondi, G., Vallaro, M., Goetz, G. H., Shalaeva, M. Y., & Caron, G. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105274 · Cited by 62
Poongavanam, V., Atilaw, Y., Ye, S., Wieske, L. H. E., Erdélyi, M., Ermondi, G., Caron, G., & Kihlberg, J. O. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.052 · Cited by 58
Self-citationConnecting Hydrophobic Surfaces in Cyclic Peptides Increases Membrane Permeability
Hoang, H. N., Hill, T. A., & Fairlie, D. P. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202012643 · Cited by 58
Bogdan, A. R., Davies, N. L., & James, K. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05996c · Cited by 57
Sheikh, A. Y., Mattei, A., Bhardwaj, R. M., Hong, R. S., Abraham, N. S., Rauber, G. S., Engstrom, K. M., Diwan, M., Henry, R. F., Gao, Y., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c06837 · Cited by 54
Aleksić, S., Seeliger, D., & Brown, J. B. (2021) · Molecular Informatics · doi:10.1002/minf.202100113 · Cited by 51
Mining Natural Products for Macrocycles to Drug Difficult Targets
Begnini, F., Poongavanam, V., Over, B., Castaldo, M., Geschwindner, S., Johansson, P., Tyagi, M., Tyrchan, C., Wissler, L., Sjö, P., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01569 · Cited by 50
Self-citationTsantrizos, Y. S. (2004) · Biopolymers · doi:10.1002/bip.20127 · Cited by 43
Tyagi, M., Poongavanam, V., Lindhagen, M., Pettersen, A., Sjö, P., Schießer, S., & Kihlberg, J. O. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b02447 · Cited by 40
Self-citationNature's contribution to today's pharmacopeia
Tao, L., Zhu, F., Chu, Q., Zhang, C., Xu, F., Tan, C. Y., Jiang, Y., & Chen, Y. (2014) · Nature Biotechnology · doi:10.1038/nbt.3034 · Cited by 35
Maggio, E., & Grasso, P. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.009 · Cited by 35
Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds
Wieske, L. H. E., Atilaw, Y., Poongavanam, V., Erdélyi, M., & Kihlberg, J. O. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202202798 · Cited by 31
Self-citationConformational Effects on the Passive Membrane Permeability of Synthetic Macrocycles
Rzepiela, A. A., Viarengo‐Baker, L. A., Tatarskii, V., Kombarov, R. V., & Whitty, A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02090 · Cited by 30
Membrane Permeating Macrocycles: Design Guidelines from Machine Learning
Williams‐Noonan, B. J., Speer, M. N., Le, T. C., Sadek, M. M., Thompson, P. E., Norton, R. S., Yuriev, E., Barlow, Ν., Chalmers, D. K., & Yarovsky, I. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00809 · Cited by 22
Alehashem, M. S., Ariffin, A., Savage, P. B., Yehye, W. A., & Thomas, N. F. (2020) · RSC Advances · doi:10.1039/d0ra01132k · Cited by 18
Yang, M. G., Xiao, Z., Cherney, R. J., Tebben, A. J., Batt, D. G., Brown, G. D., Chen, J., Cvijic, M. E., Dabros, M., Duncia, J. V., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00439 · Cited by 17
Cited by
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
Cyclic Peptides for Drug Development
Ji, X., Nielsen, A. L., & Heinis, C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202308251 · Cited by 411
Advances in Ultrahigh Throughput Hit Discovery with Tandem Mass Spectrometry Encoded Libraries
Mata, J. M., van der Nol, E., & Pomplun, S. J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04899 · Cited by 27
Rossetti, P., Trollmann, M. F. W., Wichmann, C., Gutsmann, T., Eggeling, C., & Böckmann, R. A. (2026) · Small · doi:10.1002/smll.202411476 · Cited by 25
Metadata
- Authors
- Garcia Jimenez, D., Poongavanam, V., & Kihlberg, J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-04-05
- Volume
- 66
- Issue
- 8
- Pages
- 5377-5396
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4362601182
- Cited by
- 321
- References
- 72
- FWCI
- 23.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.